Efficacy and Safety of E/C/F/TAF (Genvoya®) in HIV-1/Hepatitis B Co-infected Adults
NCT02071082
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
79
Enrollment
INDUSTRY
Sponsor class
Conditions
HIV
HBV
Interventions
DRUG:
E/C/F/TAF
Sponsor
Gilead Sciences